These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 6093100)
41. Diphenylhydantoin blocks cardiac calcium channels and binds to the dihydropyridine receptor. Yatani A; Hamilton SL; Brown AM Circ Res; 1986 Sep; 59(3):356-61. PubMed ID: 2429782 [TBL] [Abstract][Full Text] [Related]
42. Comparison of [3H]nitrendipine binding to heart membranes of normotensive and spontaneously hypertensive rats. Chatelain P; Demol D; Roba J J Cardiovasc Pharmacol; 1984; 6(2):220-3. PubMed ID: 6200707 [TBL] [Abstract][Full Text] [Related]
43. Calcium antagonists High-affinity binding and inhibition of calcium transport in a clonal cell line. Toll L J Biol Chem; 1982 Nov; 257(22):13189-92. PubMed ID: 6292179 [TBL] [Abstract][Full Text] [Related]
44. Characterization of [3H]-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry. Batra S Br J Pharmacol; 1985 Aug; 85(4):767-74. PubMed ID: 2412621 [TBL] [Abstract][Full Text] [Related]
45. Putative Ca2+ channels in cardiac membranes. Subcellular distribution of [3H]nitrendipine receptors. Haase H; Vetter R; Will H; Will-Shahab L Biomed Biochim Acta; 1986; 45(1-2):S223-6. PubMed ID: 2421716 [TBL] [Abstract][Full Text] [Related]
46. Ontogenic appearance of Ca2+ channels characterized as binding sites for nitrendipine during development of nervous, skeletal and cardiac muscle systems in the rat. Kazazoglou T; Schmid A; Renaud JF; Lazdunski M FEBS Lett; 1983 Nov; 164(1):75-9. PubMed ID: 6317445 [TBL] [Abstract][Full Text] [Related]
47. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding. Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181 [TBL] [Abstract][Full Text] [Related]
48. Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels. Schwartz LM; McCleskey EW; Almers W Nature; 1985 Apr 25-May 1; 314(6013):747-51. PubMed ID: 2581141 [TBL] [Abstract][Full Text] [Related]
49. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes. Gopalakrishnan V; Triggle CR Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637 [TBL] [Abstract][Full Text] [Related]
50. [3H]nitrendipine receptors as markers of a class of putative voltage-sensitive Ca2+ channels in normal human skeletal muscle and in muscle from Duchenne muscular dystrophy patients. Desnuelle C; Renaud JF; Delpont E; Serratrice G; Lazdunski M Muscle Nerve; 1986 Feb; 9(2):148-51. PubMed ID: 2419753 [TBL] [Abstract][Full Text] [Related]
51. Voltage- and frequency-dependent modulation of L-type Ca2+ channel by MPC-1304, a novel calcium antagonist in guinea-pig hearts. Sunami A; Kanno T; Kanda A Arch Int Pharmacodyn Ther; 1995; 330(2):151-64. PubMed ID: 8861709 [TBL] [Abstract][Full Text] [Related]
52. Dihydropyridine-sensitive Ca2+ channel in aneurally cultured human muscles. Relationship between high-affinity binding site and inhibition of calcium uptake. Desnuelle C; Askanas V; Engel WK FEBS Lett; 1988 Mar; 230(1-2):95-100. PubMed ID: 2450788 [TBL] [Abstract][Full Text] [Related]
53. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists. Messing RO; Carpenter CL; Greenberg DA J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431 [TBL] [Abstract][Full Text] [Related]
54. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393 [TBL] [Abstract][Full Text] [Related]
55. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Bellemann P; Ferry D; Lübbecke F; Glossman H Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299 [TBL] [Abstract][Full Text] [Related]
56. [Biochemical and pharmacologic properties of the Ca2+ channel of skeletal muscle: appearance during myogenesis and the relation between its structure and function]. Renaud JF; Schmid A J Physiol (Paris); 1986; 81(3):177-84. PubMed ID: 2432258 [TBL] [Abstract][Full Text] [Related]
57. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors. Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785 [TBL] [Abstract][Full Text] [Related]
58. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand. Ferry DR; Goll A; Glossmann H Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422 [TBL] [Abstract][Full Text] [Related]
59. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel. Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252 [TBL] [Abstract][Full Text] [Related]
60. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells. Greenberg DA; Carpenter CL; Messing RO J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]